PATENT CLAIM ANALYSIS

Application Number: 15744532
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "007100"]

Abstract:
Provided is a composition including a combination of at least one short peptide and at least one peptide dimer, in defined ratio, to which autoantibodies found in elevated levels in schizophrenic patients bind.

Claim (Index 7):
The composition according to  claim 1 , wherein the compound of Formula (I) and (Ia) and (Ib) each X and X\u2032 independently of the other, is selected from the group consisting of LLVVG, LLVGV, LLGVV, LVLVG, LVLGV, LGLVV, LVVLG, LVGLV, LGVLV, LWGL, LVGVL, LGWL, VLLVG, VLLGV, GLLW, VLVLG, VLGLV, GLVLV, VLVGL, VLGVL, GLWL, WLLG, VGLLV, GVLLV, WLGL, VGLVL, GVLVL, WGLL, VGVLL and GWLL.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13701177', '15039681', '15994978', '14764419', '09793146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6269899856235017
- 35 USC 102 Novelty (BERT): 0.4956207942485078
- Combined Prediction Score: 0.6138530664860024
- Mean Citation Score: 181.942498
- Max Citation Score: 186.26022
- Similarity Product: 111.60947936096191

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test